Next Generation Cancer Diagnostics Market

Future Market Insights

Key Insight

The next generation cancer diagnostics market is projected to grow from USD 18.5 billion in 2025 to USD 53.1 billion by 2035, at a CAGR of 11.2%. Next Generation Sequencing will dominate with a 37.3% market share, while biomarker development will lead the application outlook segment with a 42.2% share.

September 23, 2025

Anurag Sharma

250 Pages

Cite this Report

Next Generation Cancer Diagnostics Market

https://www.futuremarketinsights.com/reports/next-generation-cancer-diagnostics-market

License

Buy Now

Summary ToC Companies

Key Players

Abbott
Agilent Technologies
F. Hoffmann-La Roche Ag
General Electric
Illumina
Dako Inc
Janssen Pharmaceuticals Inc
Koninklijke Philips NV
Novartis
Qiagen
Thermo Fisher Scientific Inc.

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Next Generation Cancer Diagnostics Market

Key Players

Similar Industry Reports